+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Regulatory Practice for Biopharmaceutical Production

  • ID: 2172374
  • Book
  • 566 Pages
  • John Wiley and Sons Ltd
1 of 3
Biotechnology represents a novel and expanding international industry bound by new and ever–changing legislature. This text provides a comprehensive overview of product–specific, international and country–specific licensing requirements and general regulatory issues in biotechnology.
Note: Product cover images may vary from those shown
2 of 3
Partial table of contents:

A U.S.

View of New Biotechnology Regulation (H. Miller).

Genetic Stability of Host Cell and Product (M. Wiebe & N. Lin).

Quality Control Issues for the New Biotechnology (S. Vargo).

Strategic Decisions in Process Design (A. Lubiniecki).

Experience in Manufacturing, Testing, and Licensing a Hepatitis B Vaccine Produced by Recombinant Technology (A. Elliott, et al.).

Tissue Plasminogen Activator: Regulatory Issues (D. Beebe & G. Murano).

Recombinant Peptide Hormones (Y.–y.

Chiu).

Cytokine and Growth Factor Products (L. Dujack & K. Zoon).

Licensing Biotechnology Facilities (R. Devine).

Computerized Systems Validation (R. Branning).

Regulation of Pharmaceuticals in Japan (M. Dibner).

Unresolved Issues (T. Copmann & J. Petricciani).

Index.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Anthony S. Lubiniecki
Susan A. Vargo
Note: Product cover images may vary from those shown
Adroll
adroll